{
    "code": "02022177",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022177",
    "time": "2020-09-18 03:49:58",
    "許可證字號": "衛署藥輸字第022177號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/05\/14",
    "發證日期": "87\/05\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202217702",
    "中文品名": "克立生注射劑",
    "英文品名": "CLEXANE INJECTION",
    "適應症": "預防手術後靜脈血栓症。\r\n於中度或高度血栓栓塞風險的病人，預防手術後靜脈血栓\r\n症，特別是在接受骨科或一般外科手術(包括癌症手術)之病\r\n人。",
    "劑型": "270注射劑",
    "包裝": "注射針筒 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ENOXAPARIN SODIUM",
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "FFR0086100  Sanofi Winthrop industrie",
            "製造廠廠址": "180 RUE JEAN-JAURES B.P. 40 94702 MAISONS ALFORT CEDEX FRANCE15,RUE DE LA VANNNE,92120-MONTROUGE,FRANCE",
            "製造廠公司地址": "15,RUE DE LA VANNNE,92120-MONTROUGE,FRANCE",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FFR0247100  SANOFI AVENTIS France",
            "製造廠廠址": "82, AVENUE RASPAIL 94250 GENTILLY FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30019010002 肝素及其鹽類Heparin and its salts",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401610",
            "成分名稱": "ENOXAPARIN SODIUM",
            "含量描述": "",
            "含量": "2000.0000000000",
            "單位": "ANTI-XA IU"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2012401610",
            "成分名稱": "ENOXAPARIN SODIUM",
            "含量描述": "",
            "含量": "4000.0000000000",
            "單位": "ANTI-XA IU"
        }
    ],
    "仿單外盒": [
        {
            "title": "Clexane 0.2ml_0.4ml_LPI_C_CCDS v14_HA comment clean 2019.10.01-108-10-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022177&Seq=041&Type=9"
        },
        {
            "title": "020221770008.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022177&Seq=008&Type=8"
        }
    ]
}